Virnich Daniel 4
4 · Oncology Institute, Inc. · Filed Dec 8, 2022
Insider Transaction Report
Form 4
Virnich Daniel
Chief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2022-12-07$0.86/sh+175,000$150,500→ 448,585 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-12-07−175,000→ 829,609 totalExercise: $0.86Exp: 2030-03-01→ Common Stock (175,000 underlying) - Exercise/Conversion
Common Stock
2022-12-07$0.86/sh+175,000$150,500→ 623,585 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2022-12-07−175,000→ 654,609 totalExercise: $0.86Exp: 2030-03-01→ Common Stock (175,000 underlying)
Footnotes (2)
- [F1]These options vest monthly for 36 months following November 12, 2021, the date of the closing of the Business Combination.
- [F2]These options vest as to 1/4th of the total number of shares subject to the option on the first anniversary of March 1, 2020 (the "Original Grant Date"), and as to 1/36th of the total number of shares monthly thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Original Grant Date, subject to continued employment through the vest date.